A controlled substance is a drug or chemical whose manufacture, possession, and use are regulated by the government. The regulation takes into account factors such as medical use, potential for abuse, and safety or dependence liability. Under the Controlled Substances Act (CSA), substances are classified into five schedules based on these criteria. Controlled substances require special prescriptions and strict protocols for prescription transmission.
Marijuana As A Schedule I Controlled Substance
Currently, cannabis is classified as a Schedule I controlled substance under the CSA. This indicates an allegedly high potential for abuse and no accepted medical use.
However, increasingly abundant scientific research and evolving public attitudes have led to recommendations for its reclassification. It should be moved to Schedule III, advocates argue. They recognize its lower abuse potential and acknowledged therapeutical benefits. The final decision lies with the Drug Enforcement Administration (DEA).
The Genesis Of The Controlled Substances Act
The CSA, enacted in 1970 during President Richard Nixon‘s administration, serves as the cornerstone of federal drug control policy in the United States. It was designed to fulfill international treaty requirements and categorizes drugs into five schedules, taking into account factors like potential for abuse and medical utility. Notably, it governs narcotics, stimulants, depressants, hallucinogens, and other chemicals.
However, it’s crucial to note that the CSA‘s implementation coincided with the launch of the War on Drugs in 1971, an initiative that ostensibly aimed to create a safer America but, in practice, disproportionately targeted minority communities. Policing practices within this context concealed underlying racial biases, leading to decades of unjust imprisonment for people of color.
The Ongoing Debate: Cannabis Legalization And The War On Drugs
Starting Black History Month, it is worth noting that the ongoing discussion surrounding cannabis legalization highlights the repercussions of the War on Drugs, particularly its role in perpetuating structural racism. While cannabis remains a Schedule I substance, the debate continues, and the legacy of the War on Drugs underscores the imperative to address racial disparities in drug policy and beyond.
Now Read: GOP Lawmakers Gripe About THC Potency, Anti-Cannabis Group Pushes Research Resolution
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving – don’t get left behind!
Curious about what’s next for the industry and how to leverage California’s unique market?
Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!
Get your tickets now to secure your spot and avoid last-minute price hikes.